Latest News

Dinesh Jain, CEO, Aagami Inc., represented half a dozen clients and met over 45 companies in San Francisco, during BioTech Showcase 2015.

Read more...

It gives us immense pleasure to announce that Mr. Michael S Rosen has joined Aagami Inc. as a partner Consultant. We see it as a major development which will bring added value to our clients while also widen our reach.

Michael is a Global senior executive and entrepreneur working since 1974, experienced in starting, growing, managing and financing for profit/not-for-profit life science and healthcare organizations, and creating life science ecosystems. At Aagami, Michael's focus would be Delivery Technologies, Medical Devices, Formulation Differentiators, M&As and Distribution/market access in Midwest US, Latin America, Israel, Germany, and Canada.

He will be attending Bangalore India Bio 2015 where he will be representing Illinois Bio Delegation and also Aagami.

Read more...

Godwyn Francis, Head - Business Development at Aagami, will be attending Bio India (Feb 09-11, 2015) at Bangalore, India. Aagami is representing several global clients in the partnering conference. 

After successful meetings recently at Bio Europe 2014, Frankfurt and  Biotech Showcase 2015, San Francisco, Aagami is keen to attend Bangalore India Bio and showcase global partnering opportunities while also promote Aagami. 

Read more...

In keeping up with the annual tradition Aagami is participating in JP Morgan Healthcare conference and BioTech Showcase this January 2015 also.

Both events are like pilgrimage for the Lifesciences Industry professionals and brings about major global partnerships and advancements. Last year Aagami had a very busy and fruitful participation with over 40 one-to-one meetings.

Read more...

Dinesh Jain, Founder CEO of Aagami, Inc. is travelling to India in December 2014 and will travel to various cities in India for prescheduled meetings to bring closure to partnering deals for four of the clients from the US, Germany and Australia.

Read more...

Enjoying the trust and appreciation of its Illinois based Laboratory Consumables manufacturer, Aagami has been appointed again for establishing distribution channel for Southern India.

In previous assignments, Aagami identified and shortlisted distribution partners for Western India and North India region, in 2 separate assignments. Aagami successfully established channel partnership in both regions.

Read more...

Aagami, Inc. is participating in BIO EUROPE 2014 (Nov 3 to 5, 2014) in Frankfurt, Germany, and is keen on meeting companies interested in partnerships and market intelligence, especially in emerging markets such as India. Please connect using the Bio Partnering system OR for direct contact, please email Godwyn Francis at This email address is being protected from spambots. You need JavaScript enabled to view it. .

Read more...

AdvaMed2014

Aagami, Inc. is participating in AdvaMed 2014: The Advanced MedTech Conference (Oct 6 -8, 2014) in Chicago, and looks forward to interacting with the Medical Technology to discuss promotion of life changing innovations, deliberate on critical issues and work together to contribute in the Industry progress.

Read more...

Aagami, is attending 2014 BIO International Convention (Jun 23-26, 2014) in San Diego, CA, represented by Founder CEO Dinesh Jain.

Read more...

In February 2014: Godwyn Francis, Business Development – Head, Aagami, will be attending Bio India (Feb 10-12, 2014) at Bangalore and Bio Asia 2014 (February 17-19, 2014) at Hyderabad, India. The key objective of attending these events is to showcase Aagami's global clients' licensing, co-development partnering opportunities.

Aagami regularly participates in Global events in Lifesciences, which are very productive platforms to facilitate partnerships. Most recently, Aagami CEO Mr Dinesh Jain participated in Biotech showcase as well as JP Morgan, meeting more than 50 companies. Many of these meetings proved to be very fruitful.

Read more...

January 27, 2014: An Oregon drug Development Company with innovative technology licensed from Portland State University, is developing two antimalarial drugs and one antibacterial. Today they have requested Aagami again to support their partnering needs with Indian Pharmaceutical companies.

In the last assignment ( in 2012), Aagami took them to 6 qualified and interested companies. As an outcome of those meetings, it was decided that the company would need further development on their programs before partnering/out-licensing. The Oregon company is now ready with their programs to go to the clinic within this year, and based on their trust and previous experience, requested Aagami to team up for partnering with Indian companies again, including the newer companies.

Read more...

Jan 07, 2013: Aagami has been chosen by an Indian company, a first win. It has been appointed by an Indian company for Out Licensing their innovatively developed anti-infective asset for the US market. Aagami looks forward to supporting its first ever Indian client to find an appropriate product company in the US market. The company has launched this asset successfully in India in Jan 2013 and partnered it for Latin America and South Africa. The asset is also about to receive market authorisation in Europe.

Read more...